DexCom, Inc. (DXCM)
85.36
-0.87
(-1.01%)
USD |
NASDAQ |
Oct 02, 16:00
85.36
0.00 (0.00%)
After-Hours: 20:00
DexCom Market Cap : 32.21B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 32.21B |
| October 01, 2026 | 32.54B |
| September 30, 2026 | 32.57B |
| September 29, 2026 | 32.70B |
| September 28, 2026 | 32.71B |
| September 25, 2026 | 32.69B |
| September 24, 2026 | 33.01B |
| September 23, 2026 | 33.11B |
| September 22, 2026 | 33.79B |
| September 21, 2026 | 33.65B |
| September 18, 2026 | 33.72B |
| September 17, 2026 | 33.18B |
| September 16, 2026 | 32.96B |
| September 15, 2026 | 32.63B |
| September 14, 2026 | 31.96B |
| September 11, 2026 | 31.34B |
| September 10, 2026 | 31.89B |
| September 09, 2026 | 31.66B |
| September 08, 2026 | 31.90B |
| September 04, 2026 | 33.17B |
| September 03, 2026 | 33.86B |
| September 02, 2026 | 33.85B |
| September 01, 2026 | 34.02B |
| August 31, 2026 | 34.37B |
| August 28, 2026 | 34.28B |
| Date | Value |
|---|---|
| August 27, 2026 | 33.70B |
| August 26, 2026 | 33.57B |
| August 25, 2026 | 33.65B |
| August 24, 2026 | 34.37B |
| August 21, 2026 | 34.85B |
| August 20, 2026 | 34.05B |
| August 19, 2026 | 33.92B |
| August 18, 2026 | 33.82B |
| August 17, 2026 | 33.50B |
| August 14, 2026 | 33.87B |
| August 13, 2026 | 34.52B |
| August 12, 2026 | 34.27B |
| August 11, 2026 | 33.79B |
| August 10, 2026 | 33.08B |
| August 07, 2026 | 31.98B |
| August 06, 2026 | 31.33B |
| August 05, 2026 | 31.20B |
| August 04, 2026 | 32.81B |
| August 03, 2026 | 32.95B |
| July 31, 2026 | 31.49B |
| July 30, 2026 | 28.13B |
| July 29, 2026 | 28.36B |
| July 28, 2026 | 28.25B |
| July 27, 2026 | 27.69B |
| July 24, 2026 | 27.61B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 168.71B |
| Insulet Corp. | 9.133B |
| Baxter International, Inc. | 12.14B |
| Stryker Corp. | 105.65B |
| Becton, Dickinson & Co. | 48.16B |
Market Cap Related Metrics
| PE Ratio | 33.69 |
| PS Ratio | 6.828 |
| PEG Ratio | 0.4356 |
| Price to Book Value | 12.29 |
| Price to Free Cash Flow | 24.15 |
| Price | 85.36 |
| Earnings Yield | 2.97% |
| PEGY Ratio | 0.4356 |
| Operating PE Ratio | 29.79 |
| Normalized PE Ratio | 33.69 |